Non-Pharmaceutical Interventions. PHEP awardees should coordinate non-pharmaceutical interventions by developing and updating plans that include documentation of the applicable jurisdictional, legal, and regulatory authorities necessary for implementation in routing and incident-specific situations. Such plans must include necessary authorization for interventions with the following elements: individuals, groups, facilities, animals, food products, public works/utilities, and travel through ports of entry for state, local and territorial jurisdictions as appropriate. Plans should include consideration of the legal and planning issues for interventions such as isolation, quarantine, school and child care closures, workplace and community organization/event closure, and restrictions on movement. HPP and PHEP awardees, HCCs, and their members must equip, train, and provide resources necessary to protect responders, employees, and their families from hazards during response and recovery operations. Personal protective equipment (PPE), MCMs, workplace violence training, psychological first aid training, and other interventions specific to an emergency are all necessary to protect responders and health care workers from illness or injury and should be readily available to the health care workforce.
Non-Pharmaceutical Interventions. PHEP
11.1 Determine Role with Partners (Awardee)
Non-Pharmaceutical Interventions. Introduction Capability Functions This capability consists of the ability to perform the following functions:
1. Engage partners and identify factors that impact non-pharmaceutical interventions
2. Determine non-pharmaceutical interventions
3. Implement non-pharmaceutical interventions
4. Monitor non-pharmaceutical interventions Alignment of Performance Measures to Capability PHEP 11.1: Determine Role with Partners (Awardee)
Non-Pharmaceutical Interventions. It is the awardee’s responsibility to determine which entity or entities is responsible for completing a performance element. This can refer to the awardee central office, its regional or district offices, local health departments, etc. All entities responsible for completion of a given performance element must have completed the performance element in order to answer “Yes” to Question 2, above. For the awardee to enter “Yes” on Question 2 for that performance element, the 5 funded LHDs (not 10) must have completed it. If the awardee itself was responsible for completion of a different performance element, it could only enter “Yes” on Question 2 for its performance element once it has been completed by the awardee. Pre-Incident Once the main office and the 4 regional offices have done so, the awardee may enter “Yes” on Question 2 for those performance elements. If, in this example, the awardee main office is the only entity responsible for completing a performance element (i.e., it does not assign any responsibility to any of its regions), then it may enter “Yes” once it (the main office) has completed the performance element. Response Proportion of key partners identified to have an incident-specific role that participated in the development or implementation of NPI during an incident Measure Applies To: Circumstances for Reporting: Data May Be Taken From: Other Considerations: States □ Annual Reporting Incident □ Optional Directly Funded Localities □ If PHEP Funds Allocated to the Capability or Contracts Plan Exercise □ Accountability Territories or Freely Associated States (Puerto Rico only) If Emergency Response Required Use of this Capability, Regardless of Funding □ Planned Event □ Data Collected By: An important dimension for evaluating the effectiveness of NPI planning and collaboration prior to an incident is assessing the participation of needed partners during an incident. Incorporating the right partners into the response is more likely to develop more timely and better NPI recommendations that have a greater chance for effective implementation and uptake in the community. In combination with special studies to assess the effectiveness of NPIs and specific outcomes (e.g., implementation, uptake, morbidity/mortality), this measure is intended to provide awardees with data to address challenges and barriers in bringing the right partners into discussions to develop and implement NPIs prior to, and during, a response. The immediate int...
Non-Pharmaceutical Interventions. Medical Countermeasure Dispensing
Non-Pharmaceutical Interventions. Develop and implement protocols for rapid and appropriate public health actions, such as controlled movement, isolation, quarantine, or public health orders. Plans should include: • Alternate travel plans for individuals subject to controlled movement who are not allowed to travel by long-distance commercial conveyances, such as aircraft, ship, bus, or train; how jurisdictions will ensure permitted travel is conducted by noncommercial conveyances. • Whether federal public health travel restrictions (Do Not Board) will be used to enforce controlled movement. • Whether specific community locations will be designated for safe housing of persons subject to restricted movement and the role of public health orders and corresponding compensation and support to be provided to individuals under a public health order. • The role of public health in coordinating with healthcare facilities and jurisdictional authorities to ensure the separation (through isolation or quarantine) of an individual or group who is reasonably believed to be infected with Ebola from those who are not infected to prevent the possible spread to others who have not been exposed. • Work with CDC’s Division of Global Migration and Quarantine (DGMQ) to screen travelers in their states who have entered the United States via cleared flights, broken itineraries, or land border crossing and have not undergone enhanced screening at one of the five airports conducting enhanced entry screening of travelers from Ebola-affected countries. Awardees will be required to conduct an initial Check and Report Ebola (CARE) screening with such travelers over the telephone, in person, or to designate appropriate public health outreach workers in local jurisdictions. • Support ongoing communication between the jurisdiction and its CDC quarantine station as applicable regarding coordination with identified hospitals that would support jurisdictional response to a communicable disease. For further information, see Interim U.S. Guidance for Monitoring and Movement of Persons with Potential Ebola Virus Exposure, including the application of movement restrictions when indicated. • Coordinate appropriate environmental cleaning and waste management in community settings (other than healthcare settings) where PUIs or those with probable or confirmed Ebola virus infections have been located.
Non-Pharmaceutical Interventions. Work for this capability will be addressed in future contract years.
Non-Pharmaceutical Interventions. Introduction identify factors that affect NPI implementation (e.g., legal barriers or intended and unintended consequences). The NPI response measure assesses a health department’s ability to bring key partners to the table to develop and/or implement an NPI at the time of an incident. Capability Functions This capability consists of the ability to perform the following functions:
1. Engage partners and identify factors that impact non-pharmaceutical interventions
2. Determine non-pharmaceutical interventions
3. Implement non-pharmaceutical interventions
4. Monitor non-pharmaceutical interventions Alignment of Performance Measures to Capability
PHEP 11.1: Determine Role with Partners How is the measure calculated? Legal Scientific Community What other requirements are there for reporting measure data? What data must be reported?
1. New - At which jurisdictional level(s) does public health have responsibility for this element? □ Awardee level (including awardee-led or operatated regions, districts, offices, etc.) □ Sub-awardee or autonomous local level entities (including autonomous regions, districts, counties, LHDs, coalitions, etc.) □ Both □ Other (please specify)
2. New - Has this element been completed by the entity/entities responsible for its completion? [Yes/No] (Please refer to the “How is this measure operationalized?” section for additional guidance)
3. New - Has this capability been exercised or demonstrated (in a real incident) in this budget period? [Yes/No]
a. Have corrective action/improvement plan items related to non-pharmaceutical interventions been identified? [Yes/No]
b. Have corrective action/improvement plan items related to non-pharmaceutical interventions been implemented? [Yes/Some/No]
4. New - Please indicate any barriers/challenges to completing the pre-incident planning elements for non-pharmaceutical interventions [Select all that apply] □ Communication □ Equipment □ Funding □ Participation □ Policies/procedures □ Resource limitations □ Staffing □ Time constraints □ Training □ Other, please specify □ None
5. New - [Optional] Please provide any additional clarifying, contextual, or other information. How is this measure operationalized? - New This measure is meant to address two key questions related to each of the elements identified as critical for this measure: (1) Which entity or entities is responsible for completing these elements?; and (2) Have they done so? Awardees are encouraged to develop internal tracking and ...
Non-Pharmaceutical Interventions. Introduction
Non-Pharmaceutical Interventions
